Jeffrey S Mathiesen Receives Stock Award at Neuroone Medical Technologies Corp (NMTC) — SEC Form 4, Apr 07, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Jeffrey S Mathiesen

Director

TXN 2026-04-03 · FILED 2026-04-07

Equity Position 156K sh 114,414 → 156,343

Equity Change +36.7% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Neuroone Medical Technologies Corp

NMTC CIK 0001500198

Reporting Owner

Name	Relationship
Jeffrey S Mathiesen CIK 0001296853	Director

Jeffrey S Mathiesen at Neuroone Medical Technologies Corp Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Neuroone Medical Technologies Corp

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-04-03	A - Award/Grant	41,929 A	$0.00	—	156,343	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Option to Purchase Common StockF2	$0.80	2026-04-03	A - Award/Grant	26,036 A	$0.00	2036-04-02	26,036 Common Stock	Direct

Footnotes (2)

F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Show more
F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Neuroone Medical Technologies Corp

GET /v1/forms/4/0001296853-26-000001 API docs